Table 1 Baseline characteristics of subjects.
Variables | Overall (n = 25,926) | Training set (n = 15,922) | Testing set (n = 10,004) | P value |
|---|---|---|---|---|
Age (median [IQR]) | 55.00 [45.00, 67.00] | 55.00 [45.00, 67.00] | 55.00 [44.00, 67.00] | 0.553 |
Drinking (%) | 6363 (24.5) | 3898 (24.5) | 2465 (24.6) | 0.784 |
Malignant.tumor (%) | 7058 (27.2) | 4382 (27.5) | 2676 (26.7) | 0.178 |
Anticoagulant (%) | 13,619 (52.5) | 8405 (52.8) | 5214 (52.1) | 0.299 |
Lymphocyte.percentage.last (median [IQR]) | 0.27 [0.19, 0.34] | 0.27 [0.19, 0.34] | 0.27 [0.19, 0.34] | 0.678 |
Neutrophil.percentage.max (median [IQR]) | 6.62 [5.83, 7.63] | 6.62 [5.83, 7.63] | 6.62 [5.82, 7.65] | 0.971 |
Red.blood.cell.last (median [IQR]) | 4.39 [4.03, 4.75] | 4.39 [4.03, 4.74] | 4.39 [4.03, 4.75] | 0.872 |
Total.bilirubin.last (median [IQR]) | 12.00 [9.00, 15.90] | 12.00 [9.06, 15.88] | 12.00 [9.00, 16.00] | 0.514 |
Direct.bilirubin.last (median [IQR]) | 3.90 [2.90, 5.40] | 3.90 [2.90, 5.39] | 3.90 [2.90, 5.40] | 0.489 |
Prothrombin.time.last (median [IQR]) | 13.00 [12.50, 13.60] | 13.00 [12.50, 13.60] | 13.00 [12.50, 13.60] | 0.562 |
Fibrinogen.last (median [IQR]) | 3.28 [2.80, 3.90] | 3.28 [2.80, 3.90] | 3.28 [2.80, 3.90] | 0.913 |
Label (%) | 269 (1.0) | 164 (1.0) | 105 (1.0) | 0.93 |
